NEU.AX - Neuren Pharmaceuticals Limited

ASX - ASX Delayed Price. Currency in AUD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,3061,6732,9314,794
Cost of Revenue12,44114,13210,0168,653
Gross Profit-11,135-12,459-7,085-3,859
Operating Expenses
Research Development----
Selling General and Administrative1,8421,8881,6901,705
Non Recurring----
Total Operating Expenses15,16717,25212,65311,410
Operating Income or Loss-13,861-15,579-9,722-6,616
Income from Continuing Operations
Total Other Income/Expenses Net31,4331,406-3,854
Earnings Before Interest and Taxes-13,861-15,579-9,722-6,616
Interest Expense----
Income Before Tax-13,858-14,146-8,316-10,470
Income Tax Expense-1,844-749--
Minority Interest---221-202
Net Income From Continuing Ops-12,014-13,397-8,316-10,470
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-12,014-13,397-8,297-10,436
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-12,014-13,397-8,297-10,436